SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

China: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...